We're unable to sign you in at this time. Please try again in a few minutes.
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......
Editorial |

The Acute Respiratory Distress Syndrome Dialing in the Evidence?

Brendan J. Clark, MD1; Marc Moss, MD1
[+] Author Affiliations
1Division of Pulmonary Sciences and Critical Care Medicine, University of Colorado School of Medicine, Aurora
JAMA. 2016;315(8):759-761. doi:10.1001/jama.2016.0292.
Text Size: A A A
Published online


Acute respiratory distress syndrome (ARDS) could be regarded as a prototypical disorder that has benefited from a bench to bedside research approach. After its original description in 1967, the complex pathophysiology of ARDS has been slowly unraveled through extensive basic and translational research. Based on this improved understanding of the mechanisms responsible for ARDS, a variety of major clinical trials were subsequently designed and conducted. Several of these clinical trials identified relatively simple and biologically plausible interventions that reduced mortality for patients with ARDS. For example, the ARDS network trial established that low tidal volume ventilation (6 mL/kg of predicted body weight) reduced mortality from 40% to 31%.1 A meta-analysis of 3 other trials demonstrated that a strategy of high positive end-expository pressure (PEEP) was associated with decreased mortality for patients with moderate to severe ARDS.2 In addition, ventilation in the prone position early in the course of moderate to severe ARDS resulted in a 16% absolute risk reduction in mortality.3 In theory, these beneficial therapies should be relatively easy to implement. They are essentially free, involve adjusting the dials on the ventilator or positioning patients, and are relatively safe.

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

First Page Preview

View Large
First page PDF preview




Also Meets CME requirements for:
Browse CME for all U.S. States
Accreditation Information
The American Medical Association is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. The AMA designates this journal-based CME activity for a maximum of 1 AMA PRA Category 1 CreditTM per course. Physicians should claim only the credit commensurate with the extent of their participation in the activity. Physicians who complete the CME course and score at least 80% correct on the quiz are eligible for AMA PRA Category 1 CreditTM.
Note: You must get at least of the answers correct to pass this quiz.
Please click the checkbox indicating that you have read the full article in order to submit your answers.
Your answers have been saved for later.
You have not filled in all the answers to complete this quiz
The following questions were not answered:
Sorry, you have unsuccessfully completed this CME quiz with a score of
The following questions were not answered correctly:
Commitment to Change (optional):
Indicate what change(s) you will implement in your practice, if any, based on this CME course.
Your quiz results:
The filled radio buttons indicate your responses. The preferred responses are highlighted
For CME Course: A Proposed Model for Initial Assessment and Management of Acute Heart Failure Syndromes
Indicate what changes(s) you will implement in your practice, if any, based on this CME course.


Some tools below are only available to our subscribers or users with an online account.

0 Citations

Sign in

Purchase Options

• Buy this article
• Subscribe to the journal
• Rent this article ?

Related Content

Customize your page view by dragging & repositioning the boxes below.

Articles Related By Topic
Related Collections
PubMed Articles